Increased immunogenicity to LipL32 of Leptospira interrogans when expressed as a fusion protein with the cholera toxin B subunit

Current Microbiology

Volumn 62, Issue 2, 2011, Pages 526-531

  Habarta, Alejandra ^a   Abreu, Patricia A E ^b   Olivera, Noelia ^a   Hauk, Pricila ^b   Cédola, Maia T ^a   Ferrer, María F ^a   Ho, Paulo L ^b   Gomez, Ricardo M ^a  

^a Inst de Biotecnología Y Biología Molecular IBBM   (Argentina)

^b INSTITUTO BUTANTAN   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN B SUBUNIT; GANGLIOSIDE GM1; HYBRID PROTEIN; OLIGOMER; OUTER MEMBRANE PROTEIN LIPL32;

ANIMAL EXPERIMENT; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CONVALESCENCE; FEMALE; IMMUNOGENICITY; LEPTOSPIRA INTERROGANS; MOLECULAR CLONING; MOUSE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FOLDING; TOXIN STRUCTURE; VACCINE PRODUCTION;

LEPTOSPIRA; LEPTOSPIRA INTERROGANS; MUS;

EID: 85028092233     PISSN: 03438651     EISSN: 14320991     Source Type: Journal    
DOI: 10.1007/s00284-010-9739-6     Document Type: Article

References (22)

1. AI Ko C Goarant M Picardeau 2009 Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen Nat Rev Microbiol 7 736 747 1:CAS:528:DC%2BD1MXhtFentLfO 10.1038/nrmicro2208 19756012
2. RA Hartskeerl 2006 Leptospirosis: current status and future trends Indian J Med Microbiol 24 309 1:STN:280:DC%2BD28jks1yisQ%3D%3D 10.4103/0255-0857.29404 17185862
3. Z Wang L Jin A Wegrzyn 2007 Leptospirosis vaccines Microb Cell Fact 6 39 10.1186/1475-2859-6-39 18072968 (Pubitemid 351234161)
4. C Branger C Sonrier B Chatrenet, et al. 2001 Identification of the hemolysis-associated protein 1 as a cross-protective immunogen of Leptospira interrogans by adenovirus-mediated vaccination Infect Immun 69 6831 6838 1:CAS:528:DC%2BD3MXnvFSqtLc%3D 10.1128/IAI.69.11.6831-6838.2001 11598056 (Pubitemid 32995442)
5. PA Cullen X Xu J Matsunaga, et al. 2005 Surfaceome of Leptospira spp. Infect Immun 73 4853 4863 1:CAS:528:DC%2BD2MXmvVCisrw%3D 10.1128/IAI.73.8.4853- 4863.2005 16040999 (Pubitemid 41105642)
6. DA Haake G Chao RL Zuerner, et al. 2000 The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection Infect Immun 68 2276 2285 1:CAS:528:DC%2BD3cXitFels7k%3D 10.1128/IAI.68.4.2276- 2285.2000 10722630 (Pubitemid 30164865)
7. RU Palaniappan S Ramanujam YF Chang 2007 Leptospirosis: pathogenesis, immunity, and diagnosis Curr Opin Infect Dis 20 284 292 10.1097/QCO. 0b013e32814a5729 17471039 (Pubitemid 46686011)
8. FK Seixas CH Fernandes DD Hartwig, et al. 2007 Evaluation of different ways of presenting LipL32 to the immune system with the aim of developing a recombinant vaccine against leptospirosis Can J Microbiol 53 472 479 1:CAS:528:DC%2BD2sXnvVartbw%3D 10.1139/W06-138 17612601 (Pubitemid 47028512)
9. P Hauk F Macedo EC Romero, et al. 2008 In LipL32, the major leptospiral lipoprotein, the C terminus is the primary immunogenic domain and mediates interaction with collagen IV and plasma fibronectin Infect Immun 76 2642 2650 1:CAS:528:DC%2BD1cXms1ens74%3D 10.1128/IAI.01639-07 18391007
10. CW Yang MS Wu MJ Pan, et al. 2002 The Leptospira outer membrane protein LipL32 induces tubulointerstitial nephritis-mediated gene expression in mouse proximal tubule cells J Am Soc Nephrol 13 2037 2045 1:CAS:528: DC%2BD38Xmt1Ogsb4%3D 10.1097/01.ASN.0000022007.91733.62 12138134 (Pubitemid 34790779)
11. C Branger B Chatrenet A Gauvrit, et al. 2005 Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysin-associated protein 1 Infect Immun 73 4062 4069 1:CAS:528:DC%2BD28XhsFWgtbo%3D 10.1128/IAI.73.7.4062-4069.2005 15972494 (Pubitemid 40923146)
12. J Sanchez J Holmgren 2008 Cholera toxin structure, gene regulation and pathophysiological and immunological aspects Cell Mol Life Sci 65 1347 1360 1:CAS:528:DC%2BD1cXltFyhtbc%3D 10.1007/s00018-008-7496-5 18278577
13. TD Connell 2007 Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heat-labile enterotoxins Expert Rev Vaccines 6 821 834 1:CAS:528:DC%2BD2sXhtFGgsr3M 10.1586/14760584.6.5.821 17931161 (Pubitemid 47607856)
14. JY Seo SY Seong BY Ahn, et al. 2002 Cross-protective immunity of mice induced by oral immunization with pneumococcal surface adhesin a encapsulated in microspheres Infect Immun 70 1143 1149 1:CAS:528:DC%2BD38XhsFSlsr4%3D 10.1128/IAI.70.3.1143-1149.2002 11854194 (Pubitemid 34163385)
15. LG Nemchinov TJ Liang MM Rifaat, et al. 2000 Development of a plant-derived subunit vaccine candidate against hepatitis C virus Arch Virol 145 2557 2573 1:CAS:528:DC%2BD3MXhtFCjsbw%3D 10.1007/s007050070008 11205105 (Pubitemid 32062441)
16. M Gamberini RM Gomez MV Atzingen, et al. 2005 Whole-genome analysis of Leptospira interrogans to identify potential vaccine candidates against leptospirosis FEMS Microbiol Lett 244 305 313 1:CAS:528:DC%2BD2MXit1Cisbk%3D 10.1016/j.femsle.2005.02.004 15766783 (Pubitemid 40342843)
17. AP Areas ML Oliveira CR Ramos, et al. 2002 Synthesis of cholera toxin B subunit gene: cloning and expression of a functional 6XHis-tagged protein in Escherichia coli Protein Expr Purif 25 481 487 10.1016/S1046-5928(02)00026-8 12182829 (Pubitemid 35293977)
18. AP Areas ML Oliveira EN Miyaji, et al. 2004 Expression and characterization of cholera toxin B-pneumococcal surface adhesin A fusion protein in Escherichia coli: ability of CTB-PsaA to induce humoral immune response in mice Biochem Biophys Res Commun 321 192 196 1:CAS:528: DC%2BD2cXlvVWisb4%3D 10.1016/j.bbrc.2004.06.118 15358234
19. A Schon E Freire 1989 Thermodynamics of intersubunit interactions in cholera toxin upon binding to the oligosaccharide portion of its cell surface receptor, ganglioside GM1 Biochemistry 28 5019 5024 1:STN:280: DyaL1Mzlt1Grsw%3D%3D 10.1021/bi00438a017 2765522 (Pubitemid 19162747)
20. K Eriksson M Fredriksson I Nordstrom, et al. 2003 Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development Infect Immun 71 1740 1747 1:CAS:528:DC%2BD3sXislOhsrg%3D 10.1128/IAI.71.4.1740-1747.2003 12654787 (Pubitemid 36368702)
21. J Holmgren C Czerkinsky 2005 Mucosal immunity and vaccines Nat Med 11 S45 S53 1:CAS:528:DC%2BD2MXjsFWmsro%3D 10.1038/nm1213 15812489 (Pubitemid 40562303)
22. A George-Chandy K Eriksson M Lebens, et al. 2001 Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells Infect Immun 69 5716 5725 1:CAS:528:DC%2BD3MXmsVarsb4%3D 10.1128/IAI.69.9.5716-5725.2001 11500448 (Pubitemid 32786510)